224 related articles for article (PubMed ID: 32992522)
1. GPR91 Receptor Mediates Protection against Doxorubicin-Induced Cardiotoxicity without Altering Its Anticancer Efficacy. An In Vitro Study on H9C2 Cardiomyoblasts and Breast Cancer-Derived MCF-7 Cells.
Dallons M; Alpan E; Schepkens C; Tagliatti V; Colet JM
Cells; 2020 Sep; 9(10):. PubMed ID: 32992522
[TBL] [Abstract][Full Text] [Related]
2. New Insights About Doxorubicin-Induced Toxicity to Cardiomyoblast-Derived H9C2 Cells and Dexrazoxane Cytoprotective Effect: Contribution of
Dallons M; Schepkens C; Dupuis A; Tagliatti V; Colet JM
Front Pharmacol; 2020; 11():79. PubMed ID: 32153402
[TBL] [Abstract][Full Text] [Related]
3. Stimulating basal mitochondrial respiration decreases doxorubicin apoptotic signaling in H9c2 cardiomyoblasts.
Deus CM; Zehowski C; Nordgren K; Wallace KB; Skildum A; Oliveira PJ
Toxicology; 2015 Aug; 334():1-11. PubMed ID: 25997894
[TBL] [Abstract][Full Text] [Related]
4. p66Shc signaling is involved in stress responses elicited by anthracycline treatment of rat cardiomyoblasts.
Sampaio SF; Branco AF; Wojtala A; Vega-Naredo I; Wieckowski MR; Oliveira PJ
Arch Toxicol; 2016 Jul; 90(7):1669-84. PubMed ID: 26318906
[TBL] [Abstract][Full Text] [Related]
5. Neferine ameliorates cardiomyoblast apoptosis induced by doxorubicin: possible role in modulating NADPH oxidase/ROS-mediated NFκB redox signaling cascade.
Priya LB; Baskaran R; Huang CY; Padma VV
Sci Rep; 2017 Sep; 7(1):12283. PubMed ID: 28947826
[TBL] [Abstract][Full Text] [Related]
6. AMPK/PGC1α activation by melatonin attenuates acute doxorubicin cardiotoxicity via alleviating mitochondrial oxidative damage and apoptosis.
Liu D; Ma Z; Di S; Yang Y; Yang J; Xu L; Reiter RJ; Qiao S; Yuan J
Free Radic Biol Med; 2018 Dec; 129():59-72. PubMed ID: 30172748
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of dioscin against doxorubicin-induced cardiotoxicity via adjusting microRNA-140-5p-mediated myocardial oxidative stress.
Zhao L; Tao X; Qi Y; Xu L; Yin L; Peng J
Redox Biol; 2018 Jun; 16():189-198. PubMed ID: 29524841
[TBL] [Abstract][Full Text] [Related]
8. Mode of treatment governs curcumin response on doxorubicin-induced toxicity in cardiomyoblasts.
Jain A; Rani V
Mol Cell Biochem; 2018 May; 442(1-2):81-96. PubMed ID: 28929270
[TBL] [Abstract][Full Text] [Related]
9. p-Coumaric acid mediated protection of H9c2 cells from Doxorubicin-induced cardiotoxicity: Involvement of augmented Nrf2 and autophagy.
Sunitha MC; Dhanyakrishnan R; PrakashKumar B; Nevin KG
Biomed Pharmacother; 2018 Jun; 102():823-832. PubMed ID: 29605770
[TBL] [Abstract][Full Text] [Related]
10. A novel compound DT-010 protects against doxorubicin-induced cardiotoxicity in zebrafish and H9c2 cells by inhibiting reactive oxygen species-mediated apoptotic and autophagic pathways.
Tang F; Zhou X; Wang L; Shan L; Li C; Zhou H; Lee SM; Hoi MP
Eur J Pharmacol; 2018 Feb; 820():86-96. PubMed ID: 29229534
[TBL] [Abstract][Full Text] [Related]
11. Glycyrrhiza glabra (Licorice) root extract attenuates doxorubicin-induced cardiotoxicity via alleviating oxidative stress and stabilising the cardiac health in H9c2 cardiomyocytes.
Upadhyay S; Mantha AK; Dhiman M
J Ethnopharmacol; 2020 Aug; 258():112690. PubMed ID: 32105749
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-140-5p aggravates doxorubicin-induced cardiotoxicity by promoting myocardial oxidative stress via targeting Nrf2 and Sirt2.
Zhao L; Qi Y; Xu L; Tao X; Han X; Yin L; Peng J
Redox Biol; 2018 May; 15():284-296. PubMed ID: 29304479
[TBL] [Abstract][Full Text] [Related]
13. Natural compound glycyrrhetinic acid protects against doxorubicin-induced cardiotoxicity by activating the Nrf2/HO-1 signaling pathway.
Cheng Y; Wu X; Nie X; Wu Y; Zhang C; Lee SM; Lv K; Leung GP; Fu C; Zhang J; Li J
Phytomedicine; 2022 Nov; 106():154407. PubMed ID: 36070662
[TBL] [Abstract][Full Text] [Related]
14. MSCs enhances the protective effects of valsartan on attenuating the doxorubicin-induced myocardial injury via AngII/NOX/ROS/MAPK signaling pathway.
Cheng D; Tu W; Chen L; Wang H; Wang Q; Liu H; Zhu N; Fang W; Yu Q
Aging (Albany NY); 2021 Sep; 13(18):22556-22570. PubMed ID: 34587120
[TBL] [Abstract][Full Text] [Related]
15. Glycyrrhizin improved autophagy flux via HMGB1-dependent Akt/mTOR signaling pathway to prevent Doxorubicin-induced cardiotoxicity.
Lv X; Zhu Y; Deng Y; Zhang S; Zhang Q; Zhao B; Li G
Toxicology; 2020 Aug; 441():152508. PubMed ID: 32525084
[TBL] [Abstract][Full Text] [Related]
16. Berberine-induced cardioprotection and Sirt3 modulation in doxorubicin-treated H9c2 cardiomyoblasts.
Coelho AR; Martins TR; Couto R; Deus C; Pereira CV; Simões RF; Rizvanov AA; Silva F; Cunha-Oliveira T; Oliveira PJ; Serafim TL
Biochim Biophys Acta Mol Basis Dis; 2017 Nov; 1863(11):2904-2923. PubMed ID: 28760703
[TBL] [Abstract][Full Text] [Related]
17. Everolimus prevents doxorubicin-induced apoptosis in H9c2 cardiomyocytes but not in MCF-7 cancer cells: Cardioprotective roles of autophagy, mitophagy, and AKT.
Kanno SI; Hara A
Toxicol In Vitro; 2023 Dec; 93():105698. PubMed ID: 37739323
[TBL] [Abstract][Full Text] [Related]
18. Protective Effects of
Li J; Cheng Y; Li R; Wu X; Zheng C; Shiu PH; Chan JC; Rangsinth P; Liu C; Leung SW; Lee SM; Zhang C; Fu C; Zhang J; Cheung TM; Leung GP
Oxid Med Cell Longev; 2022; 2022():9266178. PubMed ID: 35693699
[TBL] [Abstract][Full Text] [Related]
19. Carvedilol (CAR) combined with carnosic acid (CAA) attenuates doxorubicin-induced cardiotoxicity by suppressing excessive oxidative stress, inflammation, apoptosis and autophagy.
Zhang QL; Yang JJ; Zhang HS
Biomed Pharmacother; 2019 Jan; 109():71-83. PubMed ID: 30396094
[TBL] [Abstract][Full Text] [Related]
20. Cinnamic Acid Derivatives as Cardioprotective Agents against Oxidative and Structural Damage Induced by Doxorubicin.
Koczurkiewicz-Adamczyk P; Klaś K; Gunia-Krzyżak A; Piska K; Andrysiak K; Stępniewski J; Lasota S; Wójcik-Pszczoła K; Dulak J; Madeja Z; Pękala E
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
